Skip to main content
Reimbursement strategy

Market Access Strategy for Medical Devices in Europe

Strategic recommendations on the topic of market access pathways for medical devices and IVD tests

Learn more

White Paper: Market access for medical devices in Europe: England, France, Germany, Italy and Spain

Get insights from MTRC White Papers to advance your understanding of European market access for medical devices

Request free of charge
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Publication Digest: Institutionalization of Health Technology Assessment of medical devices: a cluster analysis of EU, EEA, and EFTA countries

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. 

In a recent publication, Nurchis et al. conducted a comparative analysis of how EU, European Economic Area, and European Free Trade Association countries have institutionalized health technology assessment for medical devices (HTA-MD). 

Using a 16-element analytical framework and hierarchical cluster analysis, the authors identified three models of HTA-MD governance across 21 countries: (1) regulatory systems with legally binding assessments that directly inform reimbursement, (2) mixed models combining regulatory roles, expert collaboration, formal prioritization, and Horizon Scanning, and (3) advisory systems where assessments are non-mandatory and have limited policy impact. The authors emphasized the need for prioritization processes, enhancing collaboration between assessment centers, and strengthening the link between HTA results and reimbursement decisions.

Access the full-text article here.